会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
    • 내성균에대해항생작용을갖갖는카바페넴유도체및이의제조방
    • KR100451670B1
    • 2004-10-08
    • KR1020010056740
    • 2001-09-14
    • 한국화학연구원
    • 김봉진이철해김재학정희정편도규전미애권지웅김현주
    • C07D477/14
    • Y02P20/55
    • PURPOSE: Provided are carbapenem derivatives represented by formula(1) and a preparation method thereof. The carbapenem derivatives have antibacterial activity against the resistant strains such as methicillin resistant Staphylococcus aureus(MRSA) and resistant strain against Ofloxacin. CONSTITUTION: The method of preparation comprises: reacting a compound of formula(2) with a compound of formula(3) to make an ester derivatives of carbapenem represented by formula(4); and de-protecting carboxy group and hydroxy group. In formula(1), X is S or O atom; Y is hydrogen or halogen atom on a certain location in phenyl group, or C1-2 alkoxy group; M is hydrogen atom or a pair ion forming a pharmaceutically allowable salt. In formula(2,3 and 4), R1 is hydrogen atom or hydroxy protecting group; R2 is carboxy protecting group; X is S or O atom; Y is hydrogen or halogen atom on a certain location in phenyl group.
    • 用途:提供了由式(1)表示的碳代青霉烯衍生物及其制备方法。 碳青霉烯衍生物对耐药菌株如耐甲氧西林金黄色葡萄球菌(MRSA)和抗氧氟沙星耐药菌株具有抗菌活性。 构成:制备方法包括:使式(2)化合物与式(3)化合物反应,制得式(4)代表的碳青霉烯酯衍生物; 和去保护羧基和羟基。 在式(1)中,X是S或O原子; Y是在苯基中的某个位置上的氢或卤素原子,或C1-2烷氧基; M是氢原子或形成药学上允许的盐的一对离子。 在式(2,3和4)中,R 1是氢原子或羟基保护基; R2是羧基保护基; X是S或O原子; Y在苯基的某个位置上是氢或卤素原子。
    • 7. 发明公开
    • 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
    • 具有耐药菌株抗菌活性的碳水化合物及其制备方法
    • KR1020030023968A
    • 2003-03-26
    • KR1020010056740
    • 2001-09-14
    • 한국화학연구원
    • 김봉진이철해김재학정희정편도규전미애권지웅김현주
    • C07D477/14
    • Y02P20/55
    • PURPOSE: Provided are carbapenem derivatives represented by formula(1) and a preparation method thereof. The carbapenem derivatives have antibacterial activity against the resistant strains such as methicillin resistant Staphylococcus aureus(MRSA) and resistant strain against Ofloxacin. CONSTITUTION: The method of preparation comprises: reacting a compound of formula(2) with a compound of formula(3) to make an ester derivatives of carbapenem represented by formula(4); and de-protecting carboxy group and hydroxy group. In formula(1), X is S or O atom; Y is hydrogen or halogen atom on a certain location in phenyl group, or C1-2 alkoxy group; M is hydrogen atom or a pair ion forming a pharmaceutically allowable salt. In formula(2,3 and 4), R1 is hydrogen atom or hydroxy protecting group; R2 is carboxy protecting group; X is S or O atom; Y is hydrogen or halogen atom on a certain location in phenyl group.
    • 目的:提供式(1)表示的碳青霉烯衍生物及其制备方法。 碳青霉烯衍生物对抗性菌株如耐甲氧西林金黄色葡萄球菌(MRSA)和耐氧沙星的抗性菌株具有抗菌活性。 构成:制备方法包括:使式(2)化合物与式(3)化合物反应,制得由式(4)表示的碳青霉烯的酯衍生物; 并脱保护羧基和羟基。 在式(1)中,X是S或O原子; Y是苯基或C1-2烷氧基中某一位置上的氢或卤素原子; M是氢原子或形成药学上允许的盐的成对离子。 在式(2,3和4)中,R 1是氢原子或羟基保护基; R2是羧基保护基; X是S或O原子; Y是苯基中某一位置的氢或卤素原子。